Bristol-Myers Squibb Co (BMY)

54.35 -0.04  -0.07% NYSE Mar 31, 08:08 Delayed 2m USD

Bristol-Myers Squibb Profit Margin (Quarterly):

-13.29% for Dec. 31, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Profit Margin (Quarterly) Data

View and export this data going back to 1987. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2019 -13.29%
Sept. 30, 2019 22.52%
June 30, 2019 22.83%
March 31, 2019 28.89%
Dec. 31, 2018 19.42%
Sept. 30, 2018 33.40%
June 30, 2018 6.54%
March 31, 2018 28.62%
Dec. 31, 2017 -42.72%
Sept. 30, 2017 16.08%
June 30, 2017 17.81%
March 31, 2017 31.93%
Dec. 31, 2016 17.05%
Sept. 30, 2016 24.42%
June 30, 2016 23.94%
March 31, 2016 27.21%
Dec. 31, 2015 -4.60%
Sept. 30, 2015 17.35%
June 30, 2015 -3.12%
March 31, 2015 29.35%
Dec. 31, 2014 0.31%
Sept. 30, 2014 18.39%
June 30, 2014 8.56%
March 31, 2014 24.59%
Dec. 31, 2013 16.35%
   
Sept. 30, 2013 17.02%
June 30, 2013 13.24%
March 31, 2013 15.90%
Dec. 31, 2012 22.07%
Sept. 30, 2012 -19.03%
June 30, 2012 14.52%
March 31, 2012 20.97%
Dec. 31, 2011 15.62%
Sept. 30, 2011 18.13%
June 30, 2011 16.60%
March 31, 2011 19.68%
Dec. 31, 2010 9.45%
Sept. 30, 2010 19.78%
June 30, 2010 19.44%
March 31, 2010 15.46%
Dec. 31, 2009
Sept. 30, 2009 20.18%
June 30, 2009 21.07%
March 31, 2009 14.76%
Dec. 31, 2008 52.56%
Sept. 30, 2008 49.07%
June 30, 2008 14.68%
March 31, 2008 13.51%
Dec. 31, 2007 -1.43%
Sept. 30, 2007 18.65%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Benchmarks

Benchmarks
Amgen Inc 27.48%
Biogen Inc 39.22%
Gilead Sciences Inc 45.86%

Profit Margin (Quarterly) Range, Past 5 Years

Minimum -42.72% Dec 2017
Maximum 33.40% Sep 2018
Average 15.18%
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.